Comparison of three therapeutic regimens for genotype‐3 hepatitis C virus infection in a large real‐life multicentre cohortAlessandro Soria, G. Aimo, Guglielmo Marco Migliorino et al.|Liver International|2020Cited by 19
Real-life effectiveness and safety of Glecaprevir/Pibrentasvir among 723 Italian patients with chronic hepatitis C: The Navigator-II studyRoberta D’Ambrosio, S. Fagiuoli, L. Pasulo et al.|Journal of Hepatology|2018Cited by 12
Efficacy and safety of Elbasvir/Grazoprevir in a large real-life cohort of HCV-infected patientsM. Gambato, M.G. Pigozzi, Angiola Spinetti et al.|Digestive and Liver Disease|2019Cited by 1